Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques - sprookjes - yvandenbroek - TriplyDB

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

http://www.wikidata.org/entity/Q24612811

about

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia The potential of plants as a system for the development and production of human biologics Harnessing the protective potential of HIV-1 neutralizing antibodies Convalescent plasma: new evidence for an old therapeutic tool?Filoviruses: One of These Things is (not) Like the Other Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks Pre-symptomatic diagnosis and treatment of filovirus diseases Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection Gene delivery into plant cells for recombinant protein production.A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response Progress of vaccine and drug development for Ebola preparedness The ongoing evolution of antibody-based treatments for Ebola virus infection.Monoclonal antibodies for the treatment of Ebola virus disease.Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry Potential clinical treatment for Ebola pandemic.Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.Discovery of an antibody for pan-ebolavirus therapy Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography.Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus Chimeric plantibody passively protects mice against aerosolized ricin challenge.Possible leap ahead in filovirus therapeutics.Vaccinating captive chimpanzees to save wild chimpanzees.Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge A dead-end host: is there a way out? A position piece on the ebola virus outbreak by the international union of immunology societies.Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp Medical research: Ebola therapy protects severely ill monkeys.Treatment of ebola virus disease.Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.An update on the use of antibodies against the filoviruses.

P2860

Q24594601-627871A0-096D-402A-8BDE-4BD0065E0128 Q24604416-37B8C446-11DD-41E6-94D5-E0645AFCBDC0 Q24696012-785F3FC2-331F-4BC3-B77A-B58BB6D5ECA2 Q26747611-F9490488-A2C3-4C06-88BD-6F7DB6BB28A3 Q26766153-4127A5D2-11BC-4A68-8866-41682B0B7FDA Q26775412-A7359174-8EAE-431C-9986-C5244AE8611F Q26783063-F699B775-4FCB-4FCF-AF50-81533929FDB5 Q26783107-2753B33E-DA85-4253-92B7-C8974F0806CF Q26783378-B2FE2935-007F-4B92-92AA-A9A28958763C Q26801423-DF135C25-8759-4952-8E52-4FE17410E540 Q26823831-06BB4DDD-68FF-467F-9115-930D7C046E0B Q27324824-3A2454FF-9D8A-4FB9-93E2-0A95ED569109 Q27691364-4E23C86E-7384-487B-89E7-7EDB6BCA28FB Q30196960-1866D826-8DD6-4D53-AD0E-7FA4BA464997 Q30204870-35291F62-05E8-4039-8147-D6F349726F4C Q30235022-790AF6E8-493F-4466-B44B-4F27A6547F80 Q30245073-4B12B6FA-8855-4AA9-9B1D-EF9C176912E7 Q30251949-CB3F32EF-2E0C-493A-A618-04A25C2F365C Q30252022-E83A6590-569D-481F-8F3D-37BA3F42A4D7 Q30276615-997ADE0E-47DD-4334-A126-40C69F2E679E Q30366997-8DD3EDB2-8A1E-4E25-A972-8AFC46F12D7A Q30375073-47B5ECEF-C975-4902-9CF5-6AEE26B124E7 Q30383481-49F4D17D-5BC1-4A20-9F8F-E3EAC5AFEE4A Q30385927-AA5F4F4E-491F-4B4F-8139-D239439B3052 Q30409973-887D1DFF-F349-43FF-B216-83F6A701329A Q33417197-1F7D76C8-F420-4F02-B8C7-B49E3D70E38C Q33601893-1DD2F056-80C5-4410-9004-F1B5521AB2AA Q33701830-BCDCA00D-72F0-4FE2-AE15-67FD0B297763 Q33790197-A62B6D1D-98FE-4608-BAC2-196A193D5DF1 Q33826350-599F5A19-4D10-422A-9DE4-FD683F7A3BE6 Q33851717-15742CD9-E22F-49D2-84F0-5935DC404AFA Q34361120-EAF8D4A1-D7E5-48A0-9800-F1EB01F8FDB0 Q34424660-C6FBC2C8-C6D4-4551-9378-07FB86D8A2AD Q34426585-C5223E0F-DB27-4943-984B-562DF9E4A0C2 Q34435933-95755178-0F00-46B3-91E5-1D2ABC761CB8 Q34460182-A33AFB1B-894D-450A-AFBB-04478F459C9B Q34465812-75610D76-4603-482E-85A5-9E68D3F26150 Q34516555-95162D97-A19B-4140-87BB-6B7BE6A89415 Q34540207-8DE0D6A7-47B1-4EF9-B5B4-75759EC9F8E4 Q34657170-1073D1EB-CF79-4210-AD26-1D09255CE269

P2860

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

http://www.wikidata.org/entity/Q24612811

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@ast

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@en

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@nl

type

label

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@ast

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@en

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@nl

prefLabel

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@ast

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@en

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@nl

P1433

Q24612811-23B3630C-32D0-4FBF-9256-0048E7AB474C

P1476

Q24612811-67E332D7-4265-436E-AD4A-2B2F048A7103

P2093

Q24612811-22E356B0-9603-40DD-8EE7-61603D24176D

Q24612811-42A8BDF1-57FD-4510-A319-15CA3FD663DB

Q24612811-50F318D7-9182-4A4D-90B6-4C93A86651B6

Q24612811-5CA58A7A-DF78-4F01-ABF3-8812D3885BFA

Q24612811-66805C29-474C-49D0-B98A-877C2CFE17A1

Q24612811-66ADF00F-8FDB-4528-AD28-1B29C6786C23

Q24612811-932D7B61-1276-4B95-8F9E-6E2772286AEE

Q24612811-948CC906-74C1-4563-AD0D-AB98876A2E4C

Q24612811-A0B42D40-727C-422E-B529-3296713652E4

Q24612811-AE01BB03-71BA-4479-915F-4954B3D289A5

P2860

Q24612811-08FF87D0-2015-4898-AA9B-C3AA3766DDAF

Q24612811-0A3F8A81-7023-4DFA-96D4-2E3D4C0E0600

Q24612811-0B882A1E-D121-4256-9E60-62F050009212

Q24612811-0F9392CB-EF37-4F04-8FF7-E10B5473339D

Q24612811-24F9CC8D-24C6-443C-A03E-DC79B4E1F90B

Q24612811-285E1125-A696-47CA-80B7-FF22555725A3

Q24612811-292A04A6-8598-457B-B9EF-890FC20F529A

Q24612811-2D59F624-5F59-4673-B31C-B1B611DB5307

Q24612811-2F222633-D015-4CC6-B902-49A3B946F6B3

Q24612811-3BF9215A-F2DB-4744-BD3D-C66653CF38FC

P304

Q24612811-B07D2C3D-469B-4136-B6AD-5914D52D9850

P31

Q24612811-DD9CFAE0-2B99-4BC3-B7E1-F557A1098F71

P3181

Q24612811-C73C80BD-22B8-4A96-AFD6-13C0D0906BA6

P356

Q24612811-15FE6EFA-2D65-4240-BC07-345BD215E88C

P407

Q24612811-283CEF65-2900-4562-8426-EC953B02A36C

P433

Q24612811-479004D6-7E62-4F2B-81B8-325C343E6830

P478

Q24612811-3AA3E64C-7588-4B4C-BE6A-F2CC018AD74A

P50

Q24612811-653CF91A-DB20-4464-A132-695CBF0555B5

Q24612811-721E3DC3-7389-455D-8F72-8CB51E33F36B

P577

Q24612811-58E01D59-A348-4CB2-90B4-0B2BDAD16FB6

P698

Q24612811-F4DB4EA0-41DB-41D8-B8F5-5E835E6B5A06

P921

Q24612811-4D17BDA5-6431-4E1B-9F65-FF947DD00150

Q24612811-985BC0D5-7F79-4794-9264-1FF02B94162B

P932

Q24612811-B130EF58-2E78-4F7F-8F00-D26318DD48A5

P3181

P356

PNAS.1213709109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Delayed treatment of Ebola vir ...... protection in rhesus macaques

@en

P2093

Ashley K Johnson

http://www.w3.org/2001/XMLSchema#string

Barry Bratcher

http://www.w3.org/2001/XMLSchema#string

Calli M Lear

http://www.w3.org/2001/XMLSchema#string

Cara Working

http://www.w3.org/2001/XMLSchema#string

Corinne Scully

http://www.w3.org/2001/XMLSchema#string

Do Kim

http://www.w3.org/2001/XMLSchema#string

Ernie Hiatt

http://www.w3.org/2001/XMLSchema#string

James Pettitt

http://www.w3.org/2001/XMLSchema#string

Josh Morton

http://www.w3.org/2001/XMLSchema#string

Julia E Biggins

http://www.w3.org/2001/XMLSchema#string

P2860

Effective post-exposure treatment of Ebola infection

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.

Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

Preventing infectious disease with passive immunization.

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

The antiviral activity of antibodies in vitro and in vivo.

P304

18030-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1489566

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1213709109

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23071322

http://www.w3.org/2001/XMLSchema#string

P921

P932

3497800

http://www.w3.org/2001/XMLSchema#string